EDGAR Filing Documents for 0001493152-23-004896

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-23-004896

Filing Date

2023-02-14

Accepted

2023-02-14 16:16:07

Documents

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm iXBRL	10-Q	1067708
2		ex31-1.htm	EX-31.1	19756
3		ex31-2.htm	EX-31.2	18781
4		ex32-1.htm	EX-32.1	7610
5		ex32-2.htm	EX-32.2	7488
	Complete submission text file	0001493152-23-004896.txt		6095370

Data Files

Seq	Description	Document	Type	Size
6	XBRL SCHEMA FILE	eltp-20221231.xsd	EX-101.SCH	48048
7	XBRL CALCULATION FILE	eltp-20221231_cal.xml	EX-101.CAL	74185
8	XBRL DEFINITION FILE	eltp-20221231_def.xml	EX-101.DEF	186291
9	XBRL LABEL FILE	eltp-20221231_lab.xml	EX-101.LAB	390634
10	XBRL PRESENTATION FILE	eltp-20221231_pre.xml	EX-101.PRE	317155
78	EXTRACTED XBRL INSTANCE DOCUMENT	form10-q_htm.xml	XML	960331

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)